Mr Chris Hayward
Profiles

Mr Chris Hayward

Deputy Director of CTU and Quality Manager

Peninsula Medical School (Faculty of Health)

Chris began working in clinical trials in 2000, working for a commercial Clinical Research Organisation managing Phase I/II trials of Investigational Medicinal Products.  

In 2008 he joined a team at Plymouth University, coordinating the non-commercial CUPID trial (ISRCTN62942668), before moving into the UKCRC-registered Peninsula Clinical Trials Unit at Plymouth University (PenCTU) in 2010.  At PenCTU, Chris managed a variety of trials including Phase III CTIMPs, non-CTIMPs, pilot trials, feasibility studies and trials of complex interventions.  

After a brief spell working for University of Exeter, Chris re-joined PenCTU as Quality Assurance Manager in January 2017.

Chris is experienced in the practical, risk-based application of GCP standards and regulatory requirements and has prepared for and participated in several regulatory inspections. 

Key publications

Key publications are highlighted

Journals
Articles
Taylor RS, Sadler S, Dalal HM, Warren FC, Jolly K, Davis RC, Doherty P, Miles J, Greaves C & Wingham J 2019 'The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis' European Journal of Preventive Cardiology 26, (12) 1252-1261 , DOI
Hanemann CO, Ammoun S, Evans G, Hilton DA, Streeter A & Hayward C 2019 'Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2' Journal of Neurology, Neurosurgery and Psychiatry , DOI Open access
Nyman SR, Hayward C, Ingram W, Thomas P, Thomas S, Vassallo M, Raftery J, Allen H & Barrado-Martín Y 2018 'A randomised controlled trial comparing the effectiveness of tai chi alongside usual care with usual care alone on the postural balance of community-dwelling people with dementia: protocol for the TACIT trial (TAi ChI for people with demenTia)' BMC Geriatrics 18, (1) 263-263 Author Site , DOI Open access
Dalal HM, Taylor RS, Jolly K, Davis RC, Doherty P, Miles J, van Lingen R, Warren FC, Green C & Wingham J 2018 'The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial' European Journal of Preventive Cardiology 26, (3) 262-272 , DOI
Lang CC, Smith K, Wingham J, Eyre V, Greaves CJ, Warren FC, Green C, Jolly K, Davis RC & Doherty PJ 2018 'A randomised controlled trial of a facilitated home-based rehabilitation intervention in patients with heart failure with preserved ejection fraction and their caregivers: the REACH-HFpEF Pilot Study' BMJ Open 8, (4) Author Site , DOI
Powell RJ, Hayward CJ, Snelgrove CL, Polverino K, Park L, Chauhan R, Evans PH, Byford R, Charman C & Foy CJW 2017 'Pilot parallel randomised controlled trial of protective socks against usual care to reduce skin tears in high risk people: ‘STOPCUTS’' Pilot and Feasibility Studies 3, (1) , DOI
Pritchard C, Smith JE, Creanor S, Squire R, Barton A, Benger J, Cocking L, Ewings P, Rockett M & PASTIES writing group 2017 'The cost-effectiveness of patient-controlled analgesia vs. standard care in patients presenting to the emergency department in pain, who are subsequently admitted to hospital' Anaesthesia Author Site , DOI Open access
Hind D, Reeves BC, Bathers S, Bray C, Corkhill A, Hayward C, Harper L, Napp V, Norrie J & Speed C 2017 'Comparative costs and activity from a sample of UK clinical trials units' Trials 18, (1) , DOI Open access
Eyre V, Lang CC, Smith K, Jolly K, Davis R, Hayward C, Wingham J, Abraham C, Green C & Warren FC 2016 'Rehabilitation Enablement in Chronic Heart Failure—a facilitated self-care rehabilitation intervention in patients with heart failure with preserved ejection fraction (REACH-HFpEF) and their caregivers: rationale and protocol for a single-centre pilot randomised controlled trial' BMJ Open 6, (10) e012853-e012853 , DOI
Hayward CJ, Taylor RS & Eyre V 2015 'Clinical effectiveness and cost-effectiveness of the Rehabilitation Enablement in Chronic Heart Failure (REACH-HF) facilitated selfcare rehabilitation intervention in heart failure patients and caregivers: rationale and protocol for a multicentre randomised controlled trial' BMJ Open (5) , DOI Open access
Smith JE, Rockett M, Creanor S, Squire R, Hayward C, Ewings P, Barton A, Pritchard C, Eyre V & Cocking L 2015 'PAin SoluTions In the Emergency Setting (PASTIES)--patient controlled analgesia versus routine care in emergency department patients with non-traumatic abdominal pain: randomised trial' BMJ 350, (jun19 1) h3147-h3147 , DOI Open access
Smith JE, Rockett M, Creanor E, Squire R, Hayward C, Ewings P, Barton A, Pritchard C, Eyre V & Cocking L 2015 'PAin SoluTions In the Emergency Setting (PASTIES)--patient controlled analgesia versus routine care in emergency department patients with pain from traumatic injuries: randomised trial' BMJ 350, (jun19 2) h2988-h2988 , DOI Open access
Powell RJ, Hayward CJ, Snelgrove CL, Polverino K, Park L, Chauhan R, Evans PH, Byford R, Charman C & Foy CJW 2015 'Pilot randomised controlled trial of protective socks against usual care to reduce skin tears in high risk people “STOPCUTS”: study protocol' Pilot and Feasibility Studies 1, (1) , DOI Open access
Smith JE, Rockett M, Squire R, Hayward CJ, Creanor S, Ewings P, Barton A, Pritchard C & Benger JR 2013 'PAin SoluTions In the Emergency Setting (PASTIES); a protocol for two open-label randomised trials of patient-controlled analgesia (PCA) versus routine care in the emergency department' BMJ Open 3, (2) Author Site , DOI Open access
Conference Papers
Smith JE, Rockett M, Squire R, Hayward C, Creanor S, Ewings P, Barton A, Pritchard C & Benger J 2014 'PAIN SOLUTION IN THE EMERGENCY SETTING (PASTIES); AN OPEN-LABEL RANDOMISED TRIAL OF PATIENT-CONTROLLED ANALGESIA (PCA) VERSUS ROUTINE CARE IN PATIENTS ATTENDING THE EMERGENCY DEPARTMENT WITH TRAUMATIC INJURIES' BMJ 785.2-786 , DOI Open access
Other Publications
Hayward C Simvastatin as a neuroprotective treatment for Parkinson’s disease: a double-blind, randomised, placebo controlled futility study in patients of moderate severity. Open access